S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
AAPL   172.32 (-0.57%)
MSFT   421.61 (+0.04%)
META   494.55 (+0.14%)
GOOGL   151.06 (+0.13%)
AMZN   180.36 (+0.29%)
TSLA   178.66 (-0.65%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
AMD   179.05 (-0.30%)
BABA   72.02 (+0.60%)
T   17.54 (-0.06%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
CGC   9.40 (-1.57%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PFE   27.78 (+0.69%)
PYPL   66.60 (+0.05%)
XOM   115.48 (+0.44%)
S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
AAPL   172.32 (-0.57%)
MSFT   421.61 (+0.04%)
META   494.55 (+0.14%)
GOOGL   151.06 (+0.13%)
AMZN   180.36 (+0.29%)
TSLA   178.66 (-0.65%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
AMD   179.05 (-0.30%)
BABA   72.02 (+0.60%)
T   17.54 (-0.06%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
CGC   9.40 (-1.57%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PFE   27.78 (+0.69%)
PYPL   66.60 (+0.05%)
XOM   115.48 (+0.44%)
S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
AAPL   172.32 (-0.57%)
MSFT   421.61 (+0.04%)
META   494.55 (+0.14%)
GOOGL   151.06 (+0.13%)
AMZN   180.36 (+0.29%)
TSLA   178.66 (-0.65%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
AMD   179.05 (-0.30%)
BABA   72.02 (+0.60%)
T   17.54 (-0.06%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
CGC   9.40 (-1.57%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PFE   27.78 (+0.69%)
PYPL   66.60 (+0.05%)
XOM   115.48 (+0.44%)
S&P 500   5,246.74 (-0.03%)
DOW   39,826.92 (+0.17%)
QQQ   444.85 (+0.00%)
AAPL   172.32 (-0.57%)
MSFT   421.61 (+0.04%)
META   494.55 (+0.14%)
GOOGL   151.06 (+0.13%)
AMZN   180.36 (+0.29%)
TSLA   178.66 (-0.65%)
NVDA   899.25 (-0.36%)
NIO   4.76 (+1.93%)
AMD   179.05 (-0.30%)
BABA   72.02 (+0.60%)
T   17.54 (-0.06%)
F   13.02 (-0.31%)
MU   119.71 (+0.39%)
CGC   9.40 (-1.57%)
GE   179.97 (-0.08%)
DIS   121.22 (+0.20%)
AMC   3.75 (-13.59%)
PFE   27.78 (+0.69%)
PYPL   66.60 (+0.05%)
XOM   115.48 (+0.44%)
BATS:ARKG

ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News

$28.55
+0.65 (+2.33%)
(As of 03/27/2024 ET)
Today's Range
$27.81
$28.57
50-Day Range
$27.93
$32.97
52-Week Range
N/A
Volume
1.21 million shs
Average Volume
N/A
Market Capitalization
$1.86 billion
Assets Under Management
$1.59 billion
Dividend Yield
N/A
Net Expense Ratio
0.75%
ARKG stock logo

About ARK Genomic Revolution ETF (BATS:ARKG)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

ARKG Stock Price History

ARKG ETF News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
3 Biotech ETFs Overdue for a Bounce
ARK Genomic Revolution ETF
Trending Stocks Sent To You In Real Time
Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar!
See More Headlines
Receive ARKG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
ARK
Fund Name
ARK Genomic Revolution ETF
Tax Classification
Regulated Investment Company
Inception Date
10/31/2014
Fund Manager
Catherine Wood
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
43

Fund Statistics

Assets Under Management
$1.57 billion
Average Daily Volume
$2.05 million
Discount/Premium
-0.04%

Administrator, Advisor and Custodian

Administrator
The Bank of NewYork Mellon Corporation
Advisor
ARK Investment Management LLC
Custodian
The Bank of NewYork Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of NewYork Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
2,629
Put Options
652
Call Options
1,977

Miscellaneous

Beta
1.50
Creation Unit
50,000
Creation Fee
$500.00
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

ARK Genomic Revolution ETF Expenses

TypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.75%0.57%0.54%0.56%0.51%
Other Expenses0.00%0.71%0.54%0.52%0.58%
Total Expense0.75%0.72%0.70%0.69%0.70%
Fee Waiver0.00%-0.76%-0.54%-0.34%-0.56%
Net Expense0.75%0.59%0.60%0.63%0.58%

ARK Genomic Revolution ETF (ARKG) Holdings & Exposure

ARKG Sector Exposure

ARKG Industry Exposure


ARKG ETF - Frequently Asked Questions

How have ARKG shares performed in 2024?

ARK Genomic Revolution ETF's stock was trading at $32.81 at the beginning of the year. Since then, ARKG stock has decreased by 13.0% and is now trading at $28.56.
View the best growth stocks for 2024 here
.

What does ARKG invest in?

ARK Genomic Revolution ETF is a equity fund issued by ARK. ARKG focuses on theme investments. The fund's investments total to approximately $1.57 billion assets under management.

What is the management fee for ARK Genomic Revolution ETF?

ARK Genomic Revolution ETF's management fee is 0.75% and has no other recorded expenses or fee waivers. The net expense ratio for ARKG is 0.75%.

Who are ARK Genomic Revolution ETF's major shareholders?

ARK Genomic Revolution ETF's stock is owned by many different institutional and retail investors. Top institutional investors include IMC Chicago LLC (0.00%), BNP Paribas Financial Markets (1.78%), Wells Fargo & Company MN (1.19%), Main Management LLC (1.05%), Goldman Sachs Group Inc. (0.99%) and Goldman Sachs Group Inc. (0.99%).

How do I buy shares of ARK Genomic Revolution ETF?

Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (BATS:ARKG) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners